{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:14:11Z","timestamp":1789910051782,"version":"4.0.1"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T00:00:00Z","timestamp":1525219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272200800026C"],"award-info":[{"award-number":["HHSN272200800026C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","award":["ACT for TB\/HIV"],"award-info":[{"award-number":["ACT for TB\/HIV"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0196756","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T17:54:25Z","timestamp":1525283665000},"page":"e0196756","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Mycobactericidal activity of bedaquiline plus rifabutin or rifampin in ex vivo whole blood cultures of healthy volunteers: A randomized controlled trial"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6152-5183","authenticated-orcid":true,"given":"Robert S.","family":"Wallis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caryn E.","family":"Good","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"O\u2019Riordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Blumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. McLeod","family":"Griffiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Healan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Salata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,5,2]]},"reference":[{"key":"ref1","unstructured":"World Health Organization. Global tuberculosis report 2017. Geneva; 2017. Report No.: WHO\/HTM\/TB\/2017.23 Contract No.: WHO\/HTM\/TB\/2017.23."},{"issue":"5707","key":"ref2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis","volume":"307","author":"K Andries","year":"2005","journal-title":"Science"},{"issue":"23","key":"ref3","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMoa0808427","article-title":"The diarylquinoline TMC207 for multidrug-resistant tuberculosis","volume":"360","author":"AH Diacon","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"e30479","DOI":"10.1371\/journal.pone.0030479","article-title":"Rapid Evaluation in Whole Blood Culture of Regimens for XDR-TB Containing PNU-100480 (Sutezolid), TMC207, PA-824, SQ109, and Pyrazinamide","volume":"7","author":"RS Wallis","year":"2012","journal-title":"PLoS ONE"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1128\/AAC.05293-11","article-title":"Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosis","volume":"55","author":"R Tasneen","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/jac\/dku504","article-title":"Rifampicin and rifapentine significantly reduce concentrations of bedaquiline, a new anti-TB drug","volume":"70","author":"EM Svensson","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1128\/AAC.04171-14","article-title":"Evaluation of the pharmacokinetic interaction between repeated doses of rifapentine or rifampin and a single dose of bedaquiline in healthy adult subjects","volume":"59","author":"H Winter","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00855-17","article-title":"Impact of Rifabutin or Rifampin on Bedaquiline Safety, Tolerability, and Pharmacokinetics Assessed in a Randomized Clinical Trial with Healthy Adult Volunteers","volume":"62","author":"AM Healan","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1128\/AAC.01179-10","article-title":"Biomarker assisted dose selection for safety and efficacy in early development of PNU-100480 for tuberculosis","volume":"55","author":"RS Wallis","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1128\/AAC.01920-13","article-title":"Population Pharmacokinetic\/Pharmacodynamic Analysis of the Bactericidal Activities of Sutezolid (PNU-100480) and Its Major Metabolite against Intracellular Mycobacterium tuberculosis in Ex Vivo Whole-Blood Cultures of Patients with Pulmonary Tuberculosis","volume":"58","author":"T Zhu","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"e94462","DOI":"10.1371\/journal.pone.0094462","article-title":"Mycobactericidal activity of sutezolid (PNU-100480) in sputum (EBA) and blood (WBA) of patients with pulmonary tuberculosis","volume":"9","author":"RS Wallis","year":"2014","journal-title":"PLoS One"},{"key":"ref12","first-page":"1","article-title":"Antituberculosis Chemotherapy Progressin Respiratory Research","author":"RS Wallis","year":"2011"},{"issue":"8","key":"ref13","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1086\/319679","article-title":"A whole blood bactericidal assay for tuberculosis","volume":"183","author":"RS Wallis","year":"2001","journal-title":"J Infect Dis"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1128\/CVI.00427-13","article-title":"Inhibition of mycobacterial growth in vitro is enhanced following primary BCG vaccination but not BCG revaccination of human subjects","volume":"20","author":"HA Fletcher","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1086\/346053","article-title":"Whole blood bactericidal activity during treatment of pulmonary tuberculosis","volume":"187","author":"RS Wallis","year":"2003","journal-title":"J Infect Dis"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","first-page":"e71116","DOI":"10.1371\/journal.pone.0071116","article-title":"Month 2 culture status and treatment duration as predictors of tuberculosis relapse risk in a meta-regression model","volume":"8","author":"RS Wallis","year":"2013","journal-title":"PLoS ONE"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"e0125403","DOI":"10.1371\/journal.pone.0125403","article-title":"Month 2 culture status and treatment duration as predictors of recurrence in pulmonary tuberculosis: model validation and update","volume":"10","author":"RS Wallis","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"ref18","first-page":"CD005159","article-title":"Rifabutin for treating pulmonary tuberculosis","author":"G Davies","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1164\/ajrccm.154.5.8912765","article-title":"Efficacy and safety of rifabutin in the treatment of patients with newly diagnosed pulmonary tuberculosis","volume":"154","author":"MM McGregor","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1128\/AAC.05128-14","article-title":"Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers","volume":"59","author":"KE Dooley","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"e59414","DOI":"10.1371\/journal.pone.0059414","article-title":"The rationale for using rifabutin in the treatment of MDR and XDR tuberculosis outbreaks","volume":"8","author":"FA Sirgel","year":"2013","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijid.2017.10.013","article-title":"Treatment outcomes of rifabutin-containing regimens for rifabutin-sensitive multidrug-resistant pulmonary tuberculosis","volume":"65","author":"H Lee","year":"2017","journal-title":"Int J Infect Dis"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.rmed.2012.10.021","article-title":"The efficacy of rifabutin for rifabutin-susceptible, multidrug-resistant tuberculosis","volume":"107","author":"KW Jo","year":"2013","journal-title":"Respir Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0196756","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T16:08:36Z","timestamp":1661098116000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0196756"}},"subtitle":[],"editor":[{"given":"Petros C.","family":"Karakousis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,5,2]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0196756","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,2]]}}}